The global lung cancer surgery market size was USD 5.72 Billion in 2021 and is expected to register a revenue CAGR of 2.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of lung cancer due to sedentary lifestyle is a major factor driving market revenue growth. The most common cancer that results in mortality globally is lung cancer. In the U.S., an estimated 236,740 people were diagnosed with lung cancer in 2022. 3.08 million middle and high school children use at least one tobacco product, including e-cigarettes, while almost 40 million American adults still smoke cigarettes. The U.S. spends about USD 225 billion annually on medical treatment to cure diseases brought on by adult smoking.
The report sheds light on details about every market player in the global Lung Cancer Surgery Market along with its global status, product portfolio financial standing, and business expansion plan and license agreement. The key players in the market are adopting various key strategies such as mergers and acquisitions, partnerships, joint ventures, collaborations and product launches to strengthen their market position and enhance their product base.
Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1540